Bacteremia, also known as blood poisoning, happens when bacteria enter the bloodstream and spread through the body. Normally, the immune system fights off bacteria before they cause serious harm. But sometimes, bacteria overcome the body’s defenses, leading to dangerous infections.
If left untreated, bacteremia can turn into sepsis, a life-threatening condition that causes widespread inflammation and organ failure. Sepsis is responsible for more than one-third of hospital deaths every year.
Many people come into contact with bacteria daily without getting sick, so scientists are trying to understand why some infections turn deadly while others do not. If they can figure out how bacteria move through the body and enter the bloodstream, doctors may be able to stop these infections before they become life-threatening.
Dr. Michael Bachman and Dr. Caitlyn Holmes from the University of Michigan set out to answer an important question: How do bacteria travel from an infection site, like the lungs, into the bloodstream? Their research focused on a type of bacteria called Klebsiella pneumoniae, which often causes pneumonia and can lead to bacteremia.
Previous studies have shown that bacterial infections happen in three main stages. First, bacteria infect a specific area, such as the lungs. Then, they enter the bloodstream.
Finally, they spread and multiply while avoiding the body’s natural filters, like the liver and spleen, which try to remove harmful invaders from the blood. Scientists have ways to measure the first and third stages, but the second stage—how bacteria escape into the blood—has been much harder to study.
To solve this mystery, the researchers used a new tracking method developed with colleagues at Harvard University. They labeled bacteria with unique DNA markers and then used computer analysis to follow their movement inside infected mice.
Before starting the experiment, the team thought bacteria would remain in the lungs until they multiplied to large numbers. Then, once the infection overwhelmed the lung’s defenses, the bacteria would spill into the bloodstream in large amounts. This process, called “metastatic dissemination,” had been the widely accepted explanation for how bacteremia begins.
However, their study revealed something unexpected. While about half of the mice showed this predicted pattern, the other half had bacteria escaping into the bloodstream in a completely different way. In these cases, individual bacteria managed to break free and enter the blood without needing to multiply first. The team called this “direct dissemination.”
This discovery suggests that Klebsiella pneumoniae has two ways of spreading in the body. One way, metastatic dissemination, causes a stronger and more severe infection.
The other way, direct dissemination, allows bacteria to enter the bloodstream without first reaching high numbers in the lungs. Over time, infections seemed to shift toward the metastatic pattern, making them harder to treat.
Understanding these different pathways is important for treating bacterial infections more effectively. Doctors often follow a rule in infectious disease treatment: “Find and treat the source.”
This means that if bacteria are escaping the lungs in a low and steady trickle, they might be setting up hidden reservoirs in other parts of the body. These small reservoirs could be targeted with treatments before they grow into a full-blown infection.
The researchers also tested bacteria and mice with genetic mutations to see if certain genes affected how bacteria spread. Their findings suggested that the way bacteria interact with the immune system plays a big role in determining which route they take to enter the blood.
Dr. Holmes explained that their study started with a simple but important question: How do bacteria leave the lungs? Now, they have found a major clue. This research closes a gap in scientists’ understanding of bacterial infections and may help improve treatments for life-threatening bloodstream infections in the future.
Study Review and Analysis
This study provides key insights into how bacteria enter the bloodstream, challenging the previous assumption that they must first grow in large numbers. The discovery of two separate pathways—metastatic and direct dissemination—suggests that doctors may need different treatment strategies depending on how an infection spreads.
One of the most important findings is that some bacteria can enter the bloodstream early, even when an infection seems mild. This could explain why some patients develop bacteremia even if their lung infection does not appear severe.
It also raises new questions about whether bacteria hide in small numbers in certain areas of the body before causing a major infection later.
Another important takeaway is the role of the immune system. Since bacterial movement depends on interactions between the host and the bacteria, treatments that strengthen the immune response or target bacterial escape mechanisms could be valuable.
More research is needed to understand exactly how these interactions work and how they might differ in humans.
Overall, this study adds valuable knowledge to the field of infectious diseases and could lead to better ways to prevent and treat bloodstream infections.
The research findings can be found in Nature Communications.
Copyright © 2025 Knowridge Science Report. All rights reserved.
